Vitamin B12 supplementation did not improve cognition but reduced delirium in demented patients with vitamin B12 deficiency

Archives of Gerontology and Geriatrics

Volumn 46, Issue 3, 2008, Pages 273-282

  Kwok, Timothy ^a   Lee, Jenny ^a   Lam, Linda ^b   Woo, Jean ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cognitive disorders; Delirium; Dementia; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; MECOBALAMIN;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; CYANOCOBALAMIN DEFICIENCY; DELIRIUM; DEMENTIA; DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; COGNITION; COGNITION DISORDERS; DELIRIUM; DEMENTIA; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; VITAMIN B COMPLEX;

EID: 41249096126     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2007.05.001     Document Type: Article

References (33)

1. 12 deficiency on older veterans and its relationship to health. J. Am. Geriatr. Soc. 46 (1998) 1199-1206
2. Chan A.S., Choi A., Chiu H., and Lam L. Clinical validity of the Chinese version of Mattis Dementia Rating Scale in differentiating dementia of Alzheimer's type in Hong Kong. J. Int. Neuropsychol. Soc. 9 (2003) 45-55
3. Chiu H.F.K., Lee H.C., Chung W.S., and Kwong P.K. Reliability and validity of the Cantonese version of the Mini-Mental State Examination. A preliminary study. HK. J. Psychiatry 4 (1994) 25-28
4. 12 and folate deficiency in later life. Age Ageing 33 (2004) 34-41
5. 12 deficiency and dementia. Int. Psychogeriatr. 7 (1995) 85-88
6. Den Heijer T., Vermeer S., Clarke R., Oudkerk M., Koudstaal P.J., Hofman A., and Breteler M.M. HCY and brain atrophy on MRI of non-demented elderly. Brain 126 (2003) 170-175
7. 12 deficiency in dementia and cognitive impairment: the effect of treatment on neuropsychological function. Int. J. Geriatr. Psychiatry 15 (2000) 226-233
8. 12 deficiency: a randomized, placebo-controlled trial. Am. J. Clin. Nutr. 84 (2006) 361-370
9. Holmes J.M. Cerebral manifestations of cobalamin deficiency. Br. Med. J. 2 (1956) 1394-1398
10. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatr. 140 (1982) 556-572
11. Kalmijn S., Launer L.J., Lindemans J., Bots M.L., Hofman A., and Breteler M.M. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol. 150 (1999) 283-289
12. Lam L.C., Tang N.L., Ma S.L., Lui V.W., Chan A.S., Leung P.Y., and Chiu H.F. Apolipoprotein epsilon-4 allele and the 2-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 21 (2006) 92-99
13. Leung V.P., Lam L.C., Chiu H.F., Cummings J.L., and Chen Q.L. Validation study of the Chinese version of the neuropsychiatric inventory (CNPI). Int. J. Geriatr. Psychiatry 16 (2001) 789-793
14. 12 deficiency: cranial MRI findings. Pediatr. Radiol. 27 (1997) 155-158
15. 12 for cognition. Cochrane Database Syst. Rev. CD004326.
16. Martin D.C., Francis J., Protetch J., and Huff F.J. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J. Am. Geriatr. Soc. 40 (1992) 168-172
17. 12 deficiency and Alzheimer's disease. Neurology 58 (2002) 1395-1399
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
19. 12 and behavioral and psychological symptoms in Alzheimer's disease. Int. J. Geriatr. Psychiatry 15 (2000) 415-418
20. Mok E.H.L., Lam L.C.W., and Chiu H.F.K. Category verbal fluency test performance in Chinese elderly with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 18 (2004) 120-124
21. Nilsson K., Warkentin S., Hultberg B., Faldt R., and Gustafson L. Treatment of cobalamin deficiency in dementia, evaluated clinically and with cerebral blood flow measurements. Aging Clin. Exp. Res. (Milano) 12 (2000) 199-207
22. Nilsson K., Gustafson L., and Hultberg B. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin. Chem. 46 (2000) 691-696
23. Nilsson K., Gustafson L., and Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int. J. Geriatr. Psychiatry 16 (2001) 609-614
24. Obeid R., and Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580 (2006) 2994-3005
25. Prins N.D., Den Heijer T., Hofman A., Koudstaal P.J., Jolles J., Clarke R., Breteler M.M., and Rotterdam Scan Study. Homocysteine and cognitive function in the elderly: the Rotterdam Scan study. Neurology 59 (2002) 1375-1380
26. Roman, G.C., Tatemichi, T.K., Erkinjuntti, T., Cummings, J.L., Masdeu, J.C., Garcia, J.H., Amaducci, L., Orgogozo, J.M., Brun, A., Hofman, A., Moody, D.M., Obrien, M.D., Yamaguchi, T., Grafman, J., Drayer, B.P., Bennett, D.A., Fisher, M., Ogata, J., Kokmen, E., Bermejo, F., Wolf, P.A., Gorelick, P.B., Bick, K.L., Pajeau, A.K., Bell, M.A., Decarli, C., Culebras, A., Korczyn, A.D., Bogousslavsky, J., Hartmann, A., Scheinberg, P., 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
27. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzeheimer's disease. N. Eng. J. Med. 346 (2002) 476-483
28. 12: effect of replacement therapy on dementia. J. Neurol. 243 (1996) 522-529
29. 12 and methionine synthesis: a critical review. Is nature's most beautiful cofactor misunderstood?. Biofactors 26 (2006) 45-57
30. Trzepacz P.T., Baker R.W., and Greenhouse J. A symptom rating scale for delirium. Psychiatr. Res. 23 (1988) 89-97
31. Vermeer S.E., Van Dijk E.J., Koudstaal P.J., Oudkerk M., Hofman A., Clarke R., and Breteler M.M. Homocysteine, silent infarcts, and white matter lesions: the Rotterdam Scan study. Ann. Neurol. 51 (2002) 285-289
32. Wacker P., Nunes P.V., Cabrita H., and Forlenza O.V. Post-operative delirium is associated with poor cognitive outcome and dementia. Dement. Geriatr. Cogn. Disord. 21 (2006) 221-227
33. 12 and folate in relation to the development of Alzheimer's disease. Neurology 56 (2001) 1188-1194